Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.850
+0.030 (1.65%)
Apr 24, 2026, 10:06 AM EDT - Market open
Treace Medical Concepts Revenue
In the year 2025, Treace Medical Concepts had annual revenue of $212.69M with 1.59% growth. Treace Medical Concepts had revenue of $62.52M in the quarter ending December 31, 2025, a decrease of -9.01%.
Revenue (ttm)
$212.69M
Revenue Growth
+1.59%
P/S Ratio
0.55
Revenue / Employee
$472,644
Employees
450
Market Cap
119.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 212.69M | 3.33M | 1.59% |
| Dec 31, 2024 | 209.36M | 22.24M | 11.89% |
| Dec 31, 2023 | 187.12M | 45.28M | 31.92% |
| Dec 31, 2022 | 141.84M | 47.42M | 50.22% |
| Dec 31, 2021 | 94.42M | 37.05M | 64.59% |
| Dec 31, 2020 | 57.37M | 17.95M | 45.54% |
| Dec 31, 2019 | 39.42M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuronetics | 149.16M |
| Quanterix | 138.90M |
| Outset Medical | 119.48M |
| Owlet | 105.71M |
| AVITA Medical | 71.61M |
| Apyx Medical | 52.84M |
| SANUWAVE Health | 44.05M |
| Rapid Micro Biosystems | 33.59M |
TMCI News
- 3 hours ago - Treace to Report First Quarter 2026 Financial Results on May 8, 2026 - GlobeNewsWire
- 17 days ago - Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System - GlobeNewsWire
- 2 months ago - Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference - GlobeNewsWire
- 2 months ago - Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - GlobeNewsWire
- 3 months ago - Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - GlobeNewsWire
- 3 months ago - Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - GlobeNewsWire
- 4 months ago - Treace Medical Secures Up to $175 Million in Debt Financing - GlobeNewsWire